Atlas Trials

A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People

Clinical trial NCT06821061 · COMPLETED

Trial details

NCT number
NCT06821061
Sponsor
BioNTech SE
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
InfluenzaCOVID-19 (Coronavirus Disease 2019)
Start date
2025-02-10
Primary completion
2025-12-17
Enrollment
2650

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.